Biomarkers of Oxidative Stress Do Not Predict MACE in Type 2 Diabetes
Investigators examined 6 biomarkers for predicting adverse cardiovascular outcomes in patients with type 2 diabetes.
Investigators examined 6 biomarkers for predicting adverse cardiovascular outcomes in patients with type 2 diabetes.
Liraglutide may reduce the incidence of myocardial infarction in patients who have a high cardiovascular risk with type 2 diabetes.